20 January 2017
Dr Uccello to present at ASCO GI Symposium
Sarah Cannon Research Institute UK’s Drug Development Unit is proud to announce that Dr Mario Uccello's poster "BRAF +/- MEK inhibition in patients (pts) with BRAF-mutant (mut) metastatic colorectal cancer (mCRC): The Sarah Cannon Research Institute UK’s experience" has been selected for presentation at the ASCO 2017 Gastrointestinal Cancers Symposium, a three-day scientific and educational meeting held this weekend in in San Francisco.
View the abstract here
Download the poster from the link below:
<< Back to News